dc.contributor.author | Kenny, Rose | |
dc.contributor.author | Feeney, Joanne | |
dc.date.accessioned | 2025-02-13T08:45:58Z | |
dc.date.available | 2025-02-13T08:45:58Z | |
dc.date.issued | 2022 | |
dc.date.submitted | 2022 | en |
dc.identifier.citation | Feeney J, Kenny R.A, Hair cortisol as a risk marker for increased depressive symptoms among older adults during the COVID-19 pandemic, Psychoneuroendocrinology, 143, 2022, 105847- | en |
dc.identifier.other | Y | |
dc.description | PUBLISHED | en |
dc.description.abstract | Determining pre-existing biological risk markers of incident depression and other mental health sequelae after
exposure to a new stressor would help identify vulnerable individuals and mechanistic pathways. This study
investigated primarily whether hair cortisol predicted elevated depressive symptoms in middle-aged and older
adults during the COVID-19 pandemic, 6 years later. A secondary aim was to deduce whether any association
differed by sex.
Methods: We studied 1025 adults aged 50 and older (75% female) as part of The Irish Longitudinal Study on
Ageing. Hair cortisol samples were collected at 2014 (Wave 3) and depressive symptoms were assessed using the
8-item Center for Epidemiological Studies Depression Scale in 2014 (Wave 3), 2016 (Wave 4), 2018 (Wave 5)
and again in 2020 as part of TILDA’s COVID-19 Study. Hierarchical mixed effects logistic regression models were
applied to investigate the association between cortisol levels and clinically significant depressive symptoms
before and during the COVID-19 pandemic.
Results: In a full covariate adjusted model there was a significant interaction between cortisol and wave on
depressive symptoms (χ2 = 8.5, p = .03). Cortisol was positively and significantly associated with elevated
depressive symptoms during the COVID-19 Study (OR =1.3, 95% CI 1.11, 1.56, p = .003), and was associated
with an increased likelihood of reporting clinically significant depressive symptoms during first year of the
COVID-19 pandemic, when compared with before, OR = 1.4, 95% CI 1.05, 1.9, p = .015. There was no evidence
of effect modification by sex.
Conclusions: Higher hair cortisol, assessed 6 years previously, predicted clinically significant depressive symp-
toms among middle-aged and older adults during (but not before) the pandemic. Findings suggest a biological
phenotype which denotes increased susceptibility to the negative impact of environmental stress on psycho-
logical health. | en |
dc.format.extent | 105847 | en |
dc.language.iso | en | en |
dc.relation.ispartofseries | Psychoneuroendocrinology; | |
dc.relation.ispartofseries | 143; | |
dc.rights | Y | en |
dc.subject | Cortisol | en |
dc.subject | Stress | en |
dc.subject | Depression | en |
dc.subject | COVID-19 | en |
dc.title | Hair cortisol as a risk marker for increased depressive symptoms among older adults during the COVID-19 pandemic | en |
dc.type | Journal Article | en |
dc.type.supercollection | scholarly_publications | en |
dc.type.supercollection | refereed_publications | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/feeneyjo | |
dc.identifier.peoplefinderurl | http://people.tcd.ie/rkenny | |
dc.identifier.rssinternalid | 254825 | |
dc.identifier.doi | http://dx.doi.org/10.1016/j.psyneuen.2022.105847 | |
dc.rights.ecaccessrights | openAccess | |
dc.identifier.rssuri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85133473514&doi=10.1016%2fj.psyneuen.2022.105847&partnerID=40&md5=714057341703db4acecc544fa8e68ded | |
dc.identifier.orcid_id | 0000-0001-9872-2025 | |
dc.status.accessible | N | en |
dc.identifier.uri | https://hdl.handle.net/2262/110857 | |